Cancer Drug Parity Act of 2025
Health119-hr4101 — Cancer Drug Parity Act of 2025. Sponsored by Rep. Grothman, Glenn [R-WI-6]. Introduced 2025-06-24. House bill. 119th Congress. Latest action: Referred to the House Committee on Education and Workforce.
- Sponsor
- Rep. Grothman, Glenn [R-WI-6] (R), WI
- Introduced
- 2025-06-24
- Committees
- Education and Workforce Committee
- Latest Action
- Referred to the House Committee on Education and Workforce.
No roll-call vote data available for this bill.
Similar Bills
- 118-hr4007 — Support for Patients and Communities Reauthorization Act 100% match 118th Congress
- 118-hr4057 — Support for Patients and Communities Reauthorization Act 100% match 118th Congress
- 118-hr4100 — Support for Patients and Communities Reauthorization Act 100% match 118th Congress
- 118-hr1502 — Support for Patients and Communities Reauthorization Act 100% match 118th Congress
- 118-hr7312 — SUPPORT for Patients and Communities Reauthorization Act 100% match 118th Congress
Investigate this bill →
Beneficiary scoring, topic classification, and fiscal analysis